Luis Baretto M.B.B.S., M.D., M.H.Sc

Senior Scientific Advisor

Dr. Luis Barreto is the President of Dr. Luis Barreto & Associates, a consultancy firm specializing in vaccine development, immunization, science policy, global health and biotechnology. He is a member of the Scientific Advisory Board for the Human Health Therapeutics  Group of the , National Research Council (NRC), Canada, a  Senior Scientific Advisor to Inventprise, U.S., a member of the Scientific Advisory Board of Cansino Biologics, China, Chair of the International Data Safety Monitoring Committee for Medicago Covid Vaccine trials, Dr Barreto is  a member of the International Advisory Board of the McMaster/Maastricht/Manipal Global Health Program

Dr. Barreto was formerly Vice-President of Clinical, Medical and Regulatory Affairs, Vice-President of Immunization and Science Policy, and a member of the Senior Management Team at Sanofi Pasteur Canada, as well as a member of its Global Public Policy group. He spent more than 23 years in research and development, leading clinical trials, licensing and launching vaccines, working closely with Canadian and international investigators and policymakers, and helping to shape immunization policy in Canada and globally working closely with GAVI and WHO. Prior to joining Sanofi Pasteur Canada, he was the first Territorial Epidemiologist of the Northwest Territories.

Dr. Barreto has been/is on many volunteer boards of directors, including VIDO-InterVAC (Chair), Research Canada, March of Dimes. He has been/is on many advisory and review panels with the government of Canada and Not for Profit organisations.

Dr. Barreto is a recipient of the BIOTECanada Community Service Award, the Research Canada Award of Distinction, the BioSciences Education Canada Meritorious Service Award, and the March of Dimes Canada Paul Martin Sr. Award. He has also a recipient of the Community Service Life Sciences Ontario award.